Harrow HROW
NASDAQ HROW
$30.48 -0.13 (-0.42%)
At close: Oct 2, 2026 · 4:00 PM EDT

Harrow (HROW) Return on Sales [ROS] (2013 - 2026)

Updated

Harrow (HROW) posted Return on Sales [ROS] of -15.58% for Q2 2026, down 33.48 percentage points from 17.90% a year earlier but up 34.37 percentage points from the prior quarter.

Analysis

Harrow (HROW) Return on Sales [ROS] (2013 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at Harrow was -1.00%, down 7.32 percentage points year-over-year; for FY2025, it came in at 11.21%, up 6.79 percentage points from FY2024.

  • Annual Return on Sales [ROS] shows a five-year change of +10.42 percentage points (FY2020 to FY2025).
  • In prior years, Harrow's Return on Sales [ROS] was 4.42% in FY2024 (+4.09 pp), 0.33% in FY2023 (-1.83 pp), 2.17% in FY2022 (-0.06 pp) and 2.23% in FY2021 (+1.44 pp).
  • Quarterly Return on Sales [ROS] has run from a low of -49.95% in Q1 2026 to a high of 20.59% in Q3 2025 over five years.
  • On a year-over-year basis, Return on Sales [ROS] has declined in each of the last three quarters, with an average year-over-year change of -0.28 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q4 2024, with a gain of 32.71 percentage points; the weakest was Q2 2026, with a drop of 33.48 percentage points.
  • According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -49.95% (Q1 2026), 17.50% (Q4 2025) and 20.59% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 Harrow 1.14 Bn 816.41 Mn 50.36 Mn -15.58%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -15.58%
Mar 31, 2026 -49.95%
Dec 31, 2025 17.50%
Sep 30, 2025 20.59%
Jun 30, 2025 17.90%
Mar 31, 2025 -23.48%
Dec 31, 2024 19.30%
Sep 30, 2024 2.68%
Jun 30, 2024 3.13%
Mar 31, 2024 -20.03%
Dec 31, 2023 -13.41%
Sep 30, 2023 5.09%
Jun 30, 2023 7.03%
Mar 31, 2023 4.64%
Dec 31, 2022 -8.75%
Sep 30, 2022 -0.41%
Jun 30, 2022 7.25%
Mar 31, 2022 9.50%
Dec 31, 2021 -8.69%
Sep 30, 2021 -19.87%
API Access

Harrow Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=HROW&period=max&api_key=YOUR_API_KEY